Neurocrine(NBIX) - 2023 Q1 - Quarterly Report
Neurocrine(NBIX)2023-05-03 11:34UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or 12780 El Camino Real San Diego, CA (Address of principal executive office) 33-0525145 (IRS Employer Identification No.) 92130 (Zip Code) (858) 617-7600 (Registrant's telephone number, including area code) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA ...